Global Dermatological Therapeutics Market 2023

June 2023 | 23 pages | ID: GC060D3B8446EN
Gen Consulting Company

Abstracts

Dermatological therapeutics encompasses the medical interventions and treatments used to address a wide range of skin conditions, including acne, eczema, psoriasis, dermatitis, skin infections, skin cancer, and other dermatological disorders. It involves the use of pharmaceuticals, topical agents, and procedures to alleviate symptoms, promote healing, and improve the overall health and appearance of the skin.

The global dermatological therapeutics market is projected to rise by USD 21.5 billion by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 7.9 percent during the forecast period. Skin disorders are common worldwide, affecting millions of people. The increasing prevalence of skin conditions, such as acne, eczema, and psoriasis, drives the demand for dermatological therapeutics. The global population is aging, leading to an increased incidence of age-related skin conditions, including wrinkles, age spots, and skin cancer. The growing aging population contributes to the demand for dermatological therapeutics aimed at addressing these concerns and maintaining skin health.

Market Segmentation
This industry report offers market estimates of the global market, followed by a detailed analysis of the drug class, application, and region. The global market data on dermatological therapeutics can be segmented by drug class: anti-acne, anti-infectives, calcineurin inhibitors, corticosteroids, retinoids, others. The corticosteroids segment captured the largest share of the market in 2022. Dermatological therapeutics market is further segmented by application: alopecia areata, atopic dermatitis (eczema), herpes, psoriasis, rosacea, others. The psoriasis segment held the largest share of the global dermatological therapeutics market in 2022 and is anticipated to hold its share during the forecast period. Based on region, the dermatological therapeutics market is segmented into: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America. In 2022, North America made up the largest share of revenue generated by the dermatological therapeutics market.

Major Companies and Competitive Landscape
The global dermatological therapeutics market is highly competitive. The leading players in the dermatological therapeutics market include Abbvie Inc., Aclaris Therapeutics Inc., Almirall S.A., Amgen Inc., Aurobindo Pharma Limited, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Galderma SA, GSK plc, Johnson and Johnson (J&J), Leo Pharma AS, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why Buy This Report?
Get a detailed picture of the Global Dermatological Therapeutics Market
Identify segments/areas to invest in over the forecast period in the Global Dermatological Therapeutics Market
Understand the competitive environment, the market’s leading players
The market estimate for ease of analysis across scenarios in Excel format
Strategy consulting and research support for three months
Print authentication provided for the single-user license

Contents

PART 1. INTRODUCTION

1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience

PART 2. RESEARCH METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

PART 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET BY DRUG CLASS

5.1 Anti-acne
5.2 Anti-infectives
5.3 Calcineurin inhibitors
5.4 Corticosteroids
5.5 Retinoids
5.6 Others

PART 6. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET BY APPLICATION

6.1 Alopecia areata
6.2 Atopic dermatitis (eczema)
6.3 Herpes
6.4 Psoriasis
6.5 Rosacea
6.6 Others

PART 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET BY REGION

7.1 Asia-Pacific
7.2 Europe
7.3 North America
7.4 Middle East and Africa (MEA)
7.5 South America

PART 8. COMPANY PROFILES

8.1 Abbvie Inc.
8.2 Aclaris Therapeutics Inc.
8.3 Almirall S.A.
8.4 Amgen Inc.
8.5 Aurobindo Pharma Limited
8.6 Bausch Health Companies Inc.
8.7 Bristol-Myers Squibb Company
8.8 Eli Lilly and Company
8.9 Galderma SA
8.10 GSK plc
8.11 Johnson and Johnson (J&J)
8.12 Leo Pharma AS
8.13 Novartis AG
8.14 Pfizer Inc.
8.15 Sun Pharmaceutical Industries Ltd.
DISCLAIMER